Clinical Trials Logo

Neuralgia, Postherpetic clinical trials

View clinical trials related to Neuralgia, Postherpetic.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04530162 Withdrawn - Pain Clinical Trials

Prevention of Post Herpetic Neuralgia by Ultrasound Guided Single Nerve Block in the ED

Start date: October 1, 2021
Phase:
Study type: Observational

Herpes zoster causes significant morbidity on over 1 million Americans every year. Although the majority of herpes zoster pain will self-resolve within one week, a significant proportion of patients will develop postherpetic neuralgia (PHN), which is characterized by debilitating pain that persists more than three months after the initial symptoms. Nerve blocks have been previously studied as a method to control herpes zoster pain in outpatient pain clinics and inpatient settings. This study aims to investigate whether emergency department ultrasound guided nerve blocks can prevent PHN and effectively treat acute herpes zoster pain.

NCT ID: NCT03595046 Withdrawn - Clinical trials for Thoracic Postherpetic Neuralgia

The Evaluation of Erector Spinae Plane Block for the Pain Control of Thoracic Postherpetic Neuralgia

Start date: July 2018
Phase: N/A
Study type: Interventional

Erector spinae plane block is new interfascial plane block, and can be applied to management of thoracic neuropathic pain syndromes. The target of needle is deeper(or anterior) to the erector spinae muscle. So it is more safe and simple technique than prior technique, thoracic paravertebral block. The aim of this study is the evaluation of erector spinae plane block comparison to prevertebra block.

NCT ID: NCT02426411 Withdrawn - Clinical trials for Neuralgia, Postherpetic

Dose Ranging Trial to Determine the Safety and Efficacy of EMA401 in Patients With PHN

Start date: June 2015
Phase: Phase 2
Study type: Interventional

The study is a randomized, double blind, placebo-controlled, parallel-group comparison (two dose levels of EMA401 versus a placebo group), of safety and efficacy in patients with postherpetic neuralgia.

NCT ID: NCT01116531 Withdrawn - Clinical trials for Postherpetic Neuralgia

Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin

Start date: April 2010
Phase: Phase 4
Study type: Interventional

Tramadol is an opioid analgesic, which is widely used in the treatment of acute and neuropathic pain. Treatment of neuropathic pain often requires a combination of pain medications due to the complex nature of neuropathic pain and frequent inadequate response to drug treatment. Common drugs used concomitantly with tramadol are SNRI antidepressant duloxetine and anticonvulsants such as pregabalin. Both tramadol and duloxetine have serotonergic effects and duloxetine has also a potential to inhibit metabolism of tramadol. The objective of the study is to investigate the pharmacokinetics and pharmacodynamic interaction of oral tramadol with duloxetine and pregabalin in patients with chronic neuropathic pain due to postherpetic neuralgia or diabetic polyneuropathy. All subjects will receive tramadol and duloxetine or tramadol and pregabalin in a randomized double-blind order. Primary end point is O-desmethyltramadol concentration.

NCT ID: NCT00506610 Withdrawn - Clinical trials for Postherpetic Neuralgia

A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether T-62 is effective in providing relief of pain that can occur after an individual experiences a shingles outbreak, which is an infection in adults caused by the same virus that causes chicken pox.